hrcak mascot   Srce   HID

Sažetak sa skupa

Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157

Helena Žižek ; University of Zagreb, School of Medicine, Department of Pharmacology
Slaven Gojković ; University of Zagreb, School of Medicine, Department of Pharmacology
Zoya Jelovečki – Dokić ; University of Zagreb, School of Medicine, Department of Pharmacology
Oliver Marcel Koltay ; University of Zagreb, School of Medicine, Department of Pharmacology
Marina Madunić ; University of Zagreb, School of Medicine, Department of Pharmacology
Tajana Đurašin ; University of Zagreb, School of Medicine, Department of Pharmacology
Mariam Samar ; University of Zagreb, School of Medicine, Department of Pharmacology

Puni tekst: engleski, pdf (69 KB) str. 0-0 preuzimanja: 4* citiraj
APA 6th Edition
Žižek, H., Gojković, S., Jelovečki – Dokić, Z., Marcel Koltay, O., Madunić, M., Đurašin, T. i Samar, M. (2019). Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157. Liječnički vjesnik, 141 (suppl.1), 0-0. Preuzeto s https://hrcak.srce.hr/221909
MLA 8th Edition
Žižek, Helena, et al. "Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157." Liječnički vjesnik, vol. 141, br. suppl.1, 2019, str. 0-0. https://hrcak.srce.hr/221909. Citirano 07.12.2019.
Chicago 17th Edition
Žižek, Helena, Slaven Gojković, Zoya Jelovečki – Dokić, Oliver Marcel Koltay, Marina Madunić, Tajana Đurašin i Mariam Samar. "Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157." Liječnički vjesnik 141, br. suppl.1 (2019): 0-0. https://hrcak.srce.hr/221909
Harvard
Žižek, H., et al. (2019). 'Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157', Liječnički vjesnik, 141(suppl.1), str. 0-0. Preuzeto s: https://hrcak.srce.hr/221909 (Datum pristupa: 07.12.2019.)
Vancouver
Žižek H, Gojković S, Jelovečki – Dokić Z, Marcel Koltay O, Madunić M, Đurašin T i sur. Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157. Liječnički vjesnik [Internet]. 2019 [pristupljeno 07.12.2019.];141(suppl.1):0-0. Dostupno na: https://hrcak.srce.hr/221909
IEEE
H. Žižek, et al., "Splenectomy induced portal and caval hypertension, aortic hypotension, venous thrombosis, peaked p waves, and tachycardia. therapy with pentadecapeptide BPC 157", Liječnički vjesnik, vol.141, br. suppl.1, str. 0-0, 2019. [Online]. Dostupno na: https://hrcak.srce.hr/221909. [Citirano: 07.12.2019.]

Sažetak
We introduce BPC 157 therapy for a cluster of complications taking place after splenectomy in rats, including portal vein (PV), inferior vena cava (IVC), superior mesenteric vein (SMV) and lienal vein (LV) thrombosis, severe venous hypertension (PV, IVC), abdominal aorta (AA) hypotension, peaked P waves and tachycardia. Medication (/kg) (BPC 157 (10 μg)(treated group) or saline (5 ml)(control group)) was applied as an abdominal bath immediately after splenectomy. 10min, 3h, and 24h after splenectomy rats were assessed via electrocardiography, USB microcamera, intravascular cannulation, and thrombi extraction. Splenectomized rats exhibited PV and IVC hypertension, aortic hypotension (mmHg) (10min: 65±4 PV, 46±4 IVC, 71±3 AA; 3h: 42±4 PV, 61±4 IVC, 70±3 AA; 24h: 38±4 PV, 47±4 IVC, 68±3 AA) and thrombosis (thrombus weight, mg) (10min: 9.5±0.5 IVC, 6.6±0.9 PV, 4.8±0.9 SMV, 1.3±0.6 LV; 3h: 10.1±0.5 IVC, 5.3±0.8 PV, 19.2±0.9 SMV, 1.0±0.6 LV; 24h: 33.8±2.5 IVC, 27.5±2.9 PV, 8.8±0.9 SMV, 3.8±0.6 LV). BPC 157 normalised blood pressure (10min: 29±4 PV, 20±4 IVC, 87±3 AA; 3h: 20±4 PV, 17±4 IVC, 81±3 AA; 24h: 12±4 PV, 20±4 IVC, 82±3 AA) and reduced thrombosis (10min: 2.9±0.5 IVC, 2.6±0.9 PV, 3.2±0.3 SMV, 0.5±0.2 LV; 3h: 6.3±0.5 IVC, 2.3±0.5 PV, 5.9±0.9 SMV, 0.6±0.2 LV, 24h: 12.2±2.5 IVC, 1.9±0.5 PV, 4.8±0.9 SMV, 2.0±0.6 LV). Control group presented with peaked P waves, tachycardia and PV/SMV congestion, whereas the treated group showed none of the aforementioned phenomena. BPC 157 therapy counteracts hemodynamic disturbances, peaked P waves, and tachycardia as post-splenectomy complications.

Ključne riječi
splenectomy, venous hypertension, congestion, thrombosis, BPC 157

Hrčak ID: 221909

URI
https://hrcak.srce.hr/221909

Posjeta: 11 *